BACKGROUND: Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in >70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in >20% of Alzheimer disease (AD) and >70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C>T) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls. OBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl. METHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods. RESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele. CONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain. Copyright 2010 S. Karger AG, Basel.
BACKGROUND:Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in >70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in >20% of Alzheimer disease (AD) and >70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C>T) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls. OBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl. METHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods. RESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele. CONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain. Copyright 2010 S. Karger AG, Basel.
Authors: Thomas G Beach; Lucia Sue; Sarah Scott; Kathryn Layne; Amanda Newell; Douglas Walker; Matthew Baker; Naraju Sahara; Shu-Hui Yen; Michael Hutton; Richard Caselli; Charles Adler; Donald Connor; Marwan Sabbagh Journal: Brain Pathol Date: 2003-07 Impact factor: 6.508
Authors: Matt Farrer; Jennifer Kachergus; Lysia Forno; Sarah Lincoln; Deng-Shun Wang; Mary Hulihan; Demetrius Maraganore; Katrina Gwinn-Hardy; Zbigniew Wszolek; Dennis Dickson; J William Langston Journal: Ann Neurol Date: 2004-02 Impact factor: 10.422
Authors: K J Hatanpaa; D M Blass; O Pletnikova; B J Crain; E H Bigio; J C Hedreen; C L White; J C Troncoso Journal: Neurology Date: 2004-08-10 Impact factor: 9.910
Authors: Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton Journal: Nature Date: 2006-07-16 Impact factor: 49.962
Authors: Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo Journal: Ageing Res Rev Date: 2015-07-28 Impact factor: 10.895
Authors: Tianhua Niu; Ning Liu; Ming Zhao; Guie Xie; Lei Zhang; Jian Li; Yu-Fang Pei; Hui Shen; Xiaoying Fu; Hao He; Shan Lu; Xiang-Ding Chen; Li-Jun Tan; Tie-Lin Yang; Yan Guo; Paul J Leo; Emma L Duncan; Jie Shen; Yan-Fang Guo; Geoffrey C Nicholson; Richard L Prince; John A Eisman; Graeme Jones; Philip N Sambrook; Xiang Hu; Partha M Das; Qing Tian; Xue-Zhen Zhu; Christopher J Papasian; Matthew A Brown; André G Uitterlinden; Yu-Ping Wang; Shuanglin Xiang; Hong-Wen Deng Journal: Hum Mol Genet Date: 2015-05-04 Impact factor: 6.150
Authors: Matthew D Cykowski; Suzanne Z Powell; Paul E Schulz; Hidehiro Takei; Andreana L Rivera; Robert E Jackson; Gustavo Roman; Gregory A Jicha; Peter T Nelson Journal: Arch Pathol Lab Med Date: 2017-05-03 Impact factor: 5.534
Authors: Peter T Nelson; Yuriko Katsumata; Kwangsik Nho; Sergey C Artiushin; Gregory A Jicha; Wang-Xia Wang; Erin L Abner; Andrew J Saykin; Walter A Kukull; David W Fardo Journal: Acta Neuropathol Date: 2016-11-04 Impact factor: 17.088
Authors: David W Fardo; Yuriko Katsumata; John S K Kauwe; Yuetiva Deming; Oscar Harari; Carlos Cruchaga; Peter T Nelson Journal: Exp Gerontol Date: 2017-02-09 Impact factor: 4.032
Authors: Olga Pletnikova; Kelly L Sloane; Alan E Renton; Bryan J Traynor; Barbara J Crain; Tammy Reid; Tao Zu; Laura P W Ranum; Juan C Troncoso; Peter V Rabins; Chiadi U Onyike Journal: Neurobiol Aging Date: 2014-04-18 Impact factor: 4.673